
NEJM Publishes First Evidence of Disease Modification in Dravet Syndrome
New Study in NEJM Highlights Potential Disease-Modifying Treatment for Dravet Syndrome Biotechnology company Stoke Therapeutics and global neuroscience firm Biogen have announced the publication of important new research on the investigational medicine zorevunersen in the prestigious medical journal The New…












